Candida auris: estrategias y retos para prevenir un brote
Palabras clave:
Candida auris
Descargas
Los datos de descargas todavía no están disponibles.
Referencias bibliográficas
1. Meis JF, Chowdhary A. Candida auris: A global fungal public health threat. Lancet Infect Dis. 2018;18:1298-9. https://doi.org/10.1016/S1473-3099(18)30609-1
2. Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162-4. https://doi.org/10.3201/eid2301.161497
3. Parra-Giraldo CM, Valderrama SL, Cortes-Fraile G, Garzón JR, Ariza BE, Morio F, et al. First report of sporadic cases of Candida auris in Colombia. Int J Infect Dis. 2018;69:63-7. https://doi.org/10.1016/j.ijid.2018.01.034
4. Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis. 2019;68:15-21. https://doi.org/10.1093/cid/ciy411
5. Escandón P, Cáceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, et al. Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017. MMWR Morb Mortal Wkly Rep. 2018;67:459-60. https://doi.org/10.15585/mmwr.mm6715a6
6. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31. https://doi.org/10.1128/CMR.00029-17
7. Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90-1. https://doi.org/10.4103/0255-0857.108746
8. Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi (Basel). 2019;5. https://doi.org/10.3390/jof5040111
9. Centers for Disease Control and Prevention. Recommendations for identification of Candida auris. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/recommendations.html
10. Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallieres E, Munoz JF, Cuomo CA, et al. Identification of Candida auris using the updated 8.01 VITEK2 yeast identification system: A multilaboratory evaluation study. J Clin Microbiol. 2019;57. https://doi.org/10.1128/JCM.00884-19
11. Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: approved guideline. MM18-A. Wayne, PA: CLSI; 2008.
12. Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin Microbiol Newsl. 2017;39:99-103. https://doi.org/10.1016/j.clinmicnews.2017.06.003
13. Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T. Thinking beyond the common Candida species: need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris. J Clin Microbiol. 2017;55:3324-7. https://doi.org/10.1128/JCM.01355-17
14. Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green-based quantitative PCR assay. J Clin Microbiol. 2018;56. https://doi.org/10.1128/JCM.01337-18
15. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CL. J Clin Microbiol. 2015;53:1823-30. https://doi.org/10.1128/JCM.00367-15
16. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445-52. https://doi.org/10.1128/JCM.00630-17
17. Centers for Disease Control and Prevention. Antifungal susceptibility testing and interpretation. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candidaauris/c-auris-antifungal.html
18. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. https://doi.org/10.1186/s13756-016-0132-5
19. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrugresistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1234-7. https://doi.org/10.15585/mmwr.mm6544e1
20. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996-3005. https://doi.org/10.1128/JCM.00921-17
21. Centers for Disease Control and Prevention. Recommendations for infection prevention and control for Candida auris. 2018. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html
22. Newman E. Bleach wipes kill Candida auris. 2019. Fecha de consulta: 12 de febrero de 2020. Disponible en: https://www.mcknights.com/news/products/bleach-wipes-kill-candida-auris/
23. Dimond VJ. EPA approves diversey claim that oxiver 1 is effective against C. auris. 2019. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.hpnonline.com/evsfacility-services/article/21086724/epa-approves-diversey-claimthat-oxiver-1-is-e_ectiveagainst-c-auris
24. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50. https://doi.org/10.1093/cid/civ933
2. Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162-4. https://doi.org/10.3201/eid2301.161497
3. Parra-Giraldo CM, Valderrama SL, Cortes-Fraile G, Garzón JR, Ariza BE, Morio F, et al. First report of sporadic cases of Candida auris in Colombia. Int J Infect Dis. 2018;69:63-7. https://doi.org/10.1016/j.ijid.2018.01.034
4. Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis. 2019;68:15-21. https://doi.org/10.1093/cid/ciy411
5. Escandón P, Cáceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, et al. Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017. MMWR Morb Mortal Wkly Rep. 2018;67:459-60. https://doi.org/10.15585/mmwr.mm6715a6
6. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31. https://doi.org/10.1128/CMR.00029-17
7. Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90-1. https://doi.org/10.4103/0255-0857.108746
8. Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi (Basel). 2019;5. https://doi.org/10.3390/jof5040111
9. Centers for Disease Control and Prevention. Recommendations for identification of Candida auris. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/recommendations.html
10. Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallieres E, Munoz JF, Cuomo CA, et al. Identification of Candida auris using the updated 8.01 VITEK2 yeast identification system: A multilaboratory evaluation study. J Clin Microbiol. 2019;57. https://doi.org/10.1128/JCM.00884-19
11. Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: approved guideline. MM18-A. Wayne, PA: CLSI; 2008.
12. Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin Microbiol Newsl. 2017;39:99-103. https://doi.org/10.1016/j.clinmicnews.2017.06.003
13. Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T. Thinking beyond the common Candida species: need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris. J Clin Microbiol. 2017;55:3324-7. https://doi.org/10.1128/JCM.01355-17
14. Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green-based quantitative PCR assay. J Clin Microbiol. 2018;56. https://doi.org/10.1128/JCM.01337-18
15. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CL. J Clin Microbiol. 2015;53:1823-30. https://doi.org/10.1128/JCM.00367-15
16. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445-52. https://doi.org/10.1128/JCM.00630-17
17. Centers for Disease Control and Prevention. Antifungal susceptibility testing and interpretation. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candidaauris/c-auris-antifungal.html
18. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. https://doi.org/10.1186/s13756-016-0132-5
19. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrugresistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1234-7. https://doi.org/10.15585/mmwr.mm6544e1
20. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996-3005. https://doi.org/10.1128/JCM.00921-17
21. Centers for Disease Control and Prevention. Recommendations for infection prevention and control for Candida auris. 2018. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html
22. Newman E. Bleach wipes kill Candida auris. 2019. Fecha de consulta: 12 de febrero de 2020. Disponible en: https://www.mcknights.com/news/products/bleach-wipes-kill-candida-auris/
23. Dimond VJ. EPA approves diversey claim that oxiver 1 is effective against C. auris. 2019. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.hpnonline.com/evsfacility-services/article/21086724/epa-approves-diversey-claimthat-oxiver-1-is-e_ectiveagainst-c-auris
24. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50. https://doi.org/10.1093/cid/civ933
Cómo citar
1.
Zuluaga-Rodríguez A. Candida auris: estrategias y retos para prevenir un brote. Biomed. [Internet]. 1 de marzo de 2020 [citado 4 de abril de 2025];40(1):5-10. Disponible en: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/5454
Algunos artículos similares:
- Catalina de Bedout, Julio Ayabaca, Ricardo Vega, Matilde Méndez, Axel R. Santiago, María Lucrecia Pabón, Angela Tabares, Myrtha Arango, Angela Restrepo, Vance Newell, Evaluación de la susceptibilidad de especies de Candida al fluconazol por el método de difusión de disco. , Biomédica: Vol. 23 Núm. 1 (2003)
- Matilde Anaya, Eduardo Barbará, Jesús Padrón, Sofía F. Borrego, Oderlaise Valdés, Alian Molina, Influencia del campo magnético sobre el crecimiento de microorganismos patógenos ambientales aislados en el Archivo Nacional de la República de Cuba , Biomédica: Vol. 35 Núm. 3 (2015)
- Javier Araiza , Valentín Sánchez-Pedraza, Ana Karen Carrillo , Denise Fernández-Samar, Jazmín Tejeda, Alexandro Bonifaz, Candidiasis oral mixta en pacientes con diabetes de tipo 2: identificación y espectro de sensibilidad , Biomédica: Vol. 43 Núm. Sp. 1 (2023): Agosto, Micología médica
- Martha Puello, Gregorio Young, Paola Suárez, Actividad de fosfolipasas y proteasas en aislamientos de especies de Candida colonizadoras y causantes de vulvovaginitis en mujeres gestantes , Biomédica: Vol. 43 Núm. Sp. 1 (2023): Agosto, Micología médica
- Paola Marsela Pérez-Camacho, Carmen Vargas-Moran, Laura Torres-Cánchala , Camila Ariza-Insignares , Lina M. Sandoval-Calle , Inés Elvira Gómez-Hernández , Paula Solís-Núñez, Juliana V. Cedeño-Castaño, Ana M. Aguilar-González, Jaime Alberto Patiño-Niño, Características epidemiológicas de pacientes pediátricos con candidiasis invasora en una unidad de cuidados intensivos del suroccidente colombiano. , Biomédica: Vol. 45 Núm. 2 (2025): Publicación anticipada, junio
Publicado
2020-03-01
Número
Sección
Editorial
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
